Manipal Hospital Bhubaneswar Brings Care Closer to Home with New Cuttack Clinic

April, 22: Manipal Hospital Bhubaneswar has taken another meaningful step towards making quality healthcare more accessible with the launch of its extended healthcare wing, Manipal Clinics, in Cuttack. This initiative brings advanced medical expertise closer to communities across Odisha, easing the burden of travel and ensuring that timely care is never out of reach when it matters most. The inauguration was led by…

Continue Reading

Study Flags Impact of Excess Screen Use on Children’s Behaviour and Sleep

Jaipur, Apr 20 (BNP): A recent clinical assessment conducted at a leading government hospital in Rajasthan has brought renewed attention to the growing impact of prolonged screen exposure on children’s physical, cognitive, and emotional well-being. The findings indicate a clear association between higher daily screen use and disturbances in attention,…

Continue Reading

Glaucoma Foundation Celebrates 42nd Anniversary Honoree Pledges USD 5 Million Dollars for Glaucoma Research

Apr 18 (BNP): Philanthropy, advocacy and artistry were jointly honored at the Glaucoma Foundation’s Annual Gala on April 16, at which 300 supporters and friends gathered to celebrate the Foundation’s 42nd anniversary. The event raised $520,000 in support of cutting-edge research. Highlighting the news of the evening was the announcement…

Continue Reading

Tendo Marketplace Hits One Million Vouchers Purchased, Establishing the Standard for Price-Transparent, High-Quality Care

Accelerating adoption signals a market-wide shift toward employer and consumer-driven, bundled healthcare Philadelphia, PA — (April 16, 2026) — Tendo, a healthcare technology company committed to putting quality at the center of every care decision, today announced that its Tendo Marketplace has surpassed one million vouchers purchased nationwide, a major…

Continue Reading

CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial

Study will advance into expanded patient populations with myelodysplastic syndrome (MDS) and myelofibrosis (MF) SOUTH SAN FRANCISCO, Calif., April 15, 2026: CERo Therapeutics Holdings, Inc., (OTCQB: CERO) (“CERo” or the “Company”) an innovative cellular immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces it…

Continue Reading